510(k) device
Abbott Axsym Troponin-I Adv
Abbott Laboratories · Immunoassay Method, Troponin Subunit (MMI, Class II) · First FDA decision Sep 10, 2004, newest Jun 14, 2006Heart attack (myocardial infarction)Heart attack and heart failure blood tests
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Axsym Troponin-I Adv"
MAUDE reports
0
Brand "Axsym Troponin-I Adv", since 2015
PubMed studies
0
Mentioning "Axsym Troponin-I Adv"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Abbott Axsym Troponin-I Adv
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K060875 · Decided Jun 14, 2006 · 76 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Axsym Troponin-I Adv", any status and sponsor, newest update first.
No registered device study names "Axsym Troponin-I Adv".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Axsym Troponin-I Adv", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MMI
7,546 reports: 7,009 malfunction, 528 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1051-2009 · Started Jan 19, 2009 · Posted by FDA Apr 15, 2009
Reason given: Defective caps: Customers have observed reagent bottles not opening appropriately, which could lead to a probe crash on the instrument.
Cause as FDA categorized it: Employee error · Device type: Immunoassay Method, Troponin Subunit (MMI)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Axsym Troponin-I Adv"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MMI.
- Access hsTnIBeckman Coulter, Inc. · 510(k) 2025
- Elecsys Troponin T Gen 5Roche Diagnostics · 510(k) 2021
- i-STAT hs-TnI cartridge with the i-STAT Alinity SystemAbbott Point of Care, Inc. · 510(k) 2026
- VITROS Immunodiagnostic Products hs Troponin I Reagent PackOrtho-Clinical Diagnostics, Inc. · 510(k) 2025
- Atellica® IM High-Sensitivity Troponin I (TnIH)Siemens Healthcare Diagnostics, Inc. · 510(k) 2024
- Alinity i STAT High Sensitivity Troponin-IAbbott Laboratories Diagnostics Division · 510(k) 2023
- Vidas Troponin I Ultra (Tniu) Assay, Model 30 448bioMerieux, Inc. · 510(k) 2007
- Dimension Vista Ctni Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.